|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
|
24893135 |
2014 |
|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Canadian guideline on genetic screening for hereditary renal cell cancers.
|
24319509 |
2013 |
|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
|
20065170 |
2010 |
|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Endocrine cancer predisposition syndromes: hereditary paraganglioma, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hereditary thyroid cancer.
|
20816580 |
2010 |
|
PARAGANGLIOMAS 2 (disorder)
|
|
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.
|
28099933 |
2017 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.
|
28099933 |
2017 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
Mitochondrial matrix proteostasis is linked to hereditary paraganglioma: LON-mediated turnover of the human flavinylation factor SDH5 is regulated by its interaction with SDHA.
|
24414418 |
2014 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Mitochondrial matrix proteostasis is linked to hereditary paraganglioma: LON-mediated turnover of the human flavinylation factor SDH5 is regulated by its interaction with SDHA.
|
24414418 |
2014 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
|
21348866 |
2012 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
|
21348866 |
2012 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
|
22241717 |
2012 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
|
22241717 |
2012 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma.
|
21224366 |
2011 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
|
20071235 |
2010 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
|
20071235 |
2010 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.
|
19628817 |
2009 |
|
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.
|
19628817 |
2009 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
Genetic aspects of nonchromaffin paraganglioma.
|
6286462 |
1982 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
Familial non-chromaffinic paragangliomas (glomus tumors) : clinical aspects.
|
6264239 |
1981 |